Trials / Conditions / T-cell Malignancies
T-cell Malignancies
4 registered clinical trials studyying T-cell Malignancies — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) NCT07465835 | Electra Therapeutics Inc. | Phase 1 |
| Recruiting | A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Re NCT07070323 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |
| Recruiting | CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies NCT06316856 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |
| Recruiting | Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies NCT06316427 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |